Wegovy Tablet UK 2026: Is the New Semaglutide Pill Better Than the Injection?

The Wegovy tablet, approved by the MHRA in June 2026, contains the same active ingredient as the Wegovy injection, Semaglutide. Trial data showed the two formats produced weight loss results in a broadly comparable range. The tablet is not clinically superior or inferior to the injection. It is simply a different delivery method, and the better option depends on your daily routine, needle tolerance, and ability to follow a strict empty stomach dosing schedule.

What Is the Wegovy Tablet?

The Wegovy tablet is an oral, once daily form of Semaglutide, a GLP1 receptor agonist that reduces appetite and slows stomach emptying. It was approved in the UK in June 2026 as the first oral GLP1 medicine licensed specifically for weight management, offering a needle free alternative to the weekly Wegovy injection.Unlike a standard tablet, it must be taken first thing in the morning after fasting for at least 8 hours, swallowing the tablet whole with a small sip of plain water (up to 120 mL). The tablet must not be crushed, chewed, split or dissolved, or taken with any drink other than water. After taking your tablet, wait at least 30 minutes before eating or drinking anything or taking any other oral medicines or supplements. This requirement exists because Semaglutide is a peptide that would otherwise break down in the gut before it could be absorbed. For a full breakdown of how the tablet is formulated, dosed, and licensed in the UK, our detailed guide on Wegovy Semaglutide tablets in the UK covers the regulatory background in more depth.

Is the Wegovy Tablet the Same as Rybelsus?

No. Rybelsus is an older oral Semaglutide tablet licensed only for type 2 diabetes, at doses up to 14 mg. The new Wegovy tablet is licensed for weight management, at a higher maintenance dose of 25 mg, and follows a slower titration schedule designed to reduce side effects. The two are not interchangeable and serve different clinical purposes.

Does the Wegovy Tablet Work as Well as the Injection?

Yes, broadly. In the trial that supported UK approval, the tablet at its full maintenance dose produced an average weight loss of around 17%, closely matching results seen with the injection at its highest approved strength. The tablet is not a diluted version of the injection. For most patients, it delivers a similar magnitude of weight loss, provided the strict dosing routine is followed consistently.The reported average weight loss with Wegovy injection at the 7.2 mg dose is 20.7% of starting body weight over 72 weeks in the STEP-UP trial. A subgroup of “early responders” lost 27.7% on average, and about 33.2% of people on 7.2 mg lost at least 25% of their starting weight.

*Average weight loss at the 7.2 mg injection dose in the STEP UP trial, over 72 weeks.

What Are the Side Effects of the Wegovy Tablet?

Side effects follow a similar pattern to the injection. Nausea, constipation, and other gastrointestinal symptoms are most common during dose increases, and the same gradual titration schedule is used to manage this. Neither format is meaningfully gentler than the other in terms of tolerability. The difference is mainly about lifestyle fit rather than clinical superiority.

Who Should Choose the Tablet Over the Injection?

The tablet suits people with a genuine needle phobia, frequent travel, or a strong preference for oral medication. It also removes the need for fridge storage and sharps disposal. However, patients who struggle with structured morning routines, or who take other medications early in the day, may find the once weekly injection easier to stick to consistently, and consistency is what actually drives results with any GLP1 medicine, oral or injectable.

Is the Wegovy Tablet Available on the NHS?

Not yet. As with the original Wegovy injection at launch, private prescribing is currently the only route to access the tablet, with NHS pathways expected to follow later under specific clinical criteria. Anyone considering either option should go through a thorough clinical assessment, since BMI, weight related health conditions, and medical history all factor into whether GLP1 treatment is appropriate.

Are There Non GLP1 Weight Loss Options?

Yes. GLP1 medicines are not the only prescription route for weight loss in the UK. First generation appetite suppressant medications, such as phentermine, work through a completely different mechanism and suit a different patient profile, generally shorter term use with different side effect considerations. If you are weighing up a GLP1 pill, a GLP1 injection, or an alternative approach, it is worth reading our comparison on whether phentermine weight loss tablets are right for you before deciding on a direction.

Pill or Injection, Which Should You Choose?

Clinically, the two are close. The tablet is not a weaker alternative to the injection; in trials it delivered comparable weight loss. The real decision point is behavioural rather than medical: can you reliably take a tablet on an empty stomach every single morning, or would a once weekly injection with no daily thinking involved suit your life better?

Some patients get better real world results from the injection simply because it demands less daily discipline, which is why our Mounjaro and Wegovy injections programme remains a popular starting point for many patients.Others finally start and stick with treatment because the needle is no longer a barrier. The best way to work out which fits your circumstances is a detailed clinical consultation rather than guesswork, and that is exactly where a structured, medically supervised programme like the Wegovy Semaglutide tabletsweight loss package comes in, combining the right prescription decision with ongoing support that makes either format work. At Weight Medics, our clinical team can help you decide which option genuinely fits your goals and lifestyle. 

This article is for general information only and does not constitute medical advice. Always speak to a qualified healthcare professional before starting or changing any weight loss treatment.